Company: ISRG
Filing Date: 2025-04-23
Form Type: 10-Q
Source: 0001035267-25-000109
Chunk: 58

Company: INTUITIVE SURGICAL INC
Filing Date: 2025-04-23
Form: 10-Q
Item: Item 1
Chunk 58
---
890.6 U.S.$1,538.2 $1,238.5 OUS715.2 652.1 Total revenue$2,253.4 $1,890.6 % of Revenue – U.S.68%66%% of Revenue – OUS32%34%Instruments and accessories$1,367.7 $1,158.9 Service363.0 313.5 Operating lease revenue195.2 148.0 Total recurring revenue$1,925.9 $1,620.4 % of Total revenue 85%86%Da Vinci Surgical System Placements by RegionU.S. unit placements204 148 OUS unit placements163 165 Total unit placements*367 313 *Systems placed under fixed-payment operating lease arrangements (included in total unit placements)91 65 *Systems placed under usage-based operating lease arrangements (included in total unit placements)107 94 Da Vinci Surgical System Placements involving Trade-ins or Lease UpgradesUnit placements involving trade-ins or lease upgrades67 29 Unit placements not involving trade-ins or lease upgrades300 284 Ion System Placements**49 70 **Systems placed under fixed-payment operating lease arrangements (included in total unit placements)14 26 **Systems placed under usage-based operating lease arrangements (included in total unit placements)15 13 

Product Revenue

Product revenue increased by 20% to $1.89 billion for the three months ended March 31, 2025, compared to $1.58 billion for the three months ended March 31, 2024.

Instruments and accessories revenue increased by 18% to $1.37 billion for the three months ended March 31, 2025, compared to $1.16 billion for the three months ended March 31, 2024. The increase in instruments and accessories revenue was primarily driven by approximately 17% higher da Vinci procedure volume and approximately 58% higher Ion procedure volume. The first quarter 2025 U.S. da Vinci procedure growth was approximately 13%, driven primarily by strong growth in 

37

general surgery procedures, most notably cholecystectomy and hernia repair procedures. The number of U.S. da Vinci bariatric procedures performed continued to decline in the mid-single digits in the first quarter of 2025 compared to the first quarter of 2024. The first quarter 2025 OUS da Vinci procedure growth was